Scenarios that move ENGN

enGene Therapeutics Inc. - Common Stock

Scenarios that move ENGN: 1 analysis, 0 positive, 1 negative.

  1. · FDA expands ImmunityBio's Anktiva label for bladder cancer — ▼ · impact -40 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing